{"prompt": "['MC1752', '69', 'We note that we will review Grade 4 and 5 adverse events deemed \"unrelated\" or', '\"unlikely to be related\", to verify their attribution and to monitor the emergence of a', 'previously unrecognized treatment-related adverse event.', '16.5', 'Results Reporting on ClinicalTrials.gov: At study activation, this study will have been', 'registered within the \"ClincialTrails.gov\" website. The Primary and Secondary', 'Endpoints (i.e., \"Outcome Measures\") along with other required information for this', 'study will be reported on ClinicalTrials.gov. For purposes of timing of the Results', 'Reporting, the initial estimated completion date for the Primary Endpoint of this study is', '26 months after the study opens to accrual. The definition of \"Primary Endpoint', 'Completion Date\" (PECD) for this study is at the time the last patient registered has', 'completed the 6 months post-registration clinical follow-up.', '16.6', 'Inclusion of Women and Minorities', '16.61', 'This study will be available to all eligible patients, regardless of race, gender, or', 'ethnic origin.', '16.62', 'There is no information currently available regarding differential effects of this', 'treatment regimen in subsets defined by race, gender, or ethnicity, and there is', 'no reason to expect such differences to exist. Therefore, although the planned', 'analysis will, as always, look for differences in treatment effect based on racial', 'and gender groupings, the sample size is not increased in order to provide', 'additional power for subset analyses.', '16.63 Based on prior MCCC studies involving similar disease sites, we expect about', '5% of patients will be classified as minorities by race and 25% of patients will be', 'women. Expected sizes of racial by gender subsets are shown in the following', 'table:', 'Accrual Targets', 'Sex/Gender', 'Ethnic Category', 'Females', 'Males', 'Total', 'Hispanic or Latino', '1', '2', '3', 'Not Hispanic or Latino', '6', '21', '27', 'Ethnic Category: Total of all subjects', '7', '23', '30', 'American Indian or Alaskan Native', '0', '1', '1', 'Asian', '0', '0', '0', 'Black or African American', '0', '0', '0', 'Native Hawaiian or other Pacific Islander', '0', '0', '0', 'Protocol Version Date: 21JUN2018']['MC1752', '70', 'Accrual Targets', 'Sex/Gender', 'Ethnic Category', 'Females', 'Males', 'Total', 'White', '7', '22', '29', 'Racial Category: Total of all subjects', '7', '23', '30', 'Ethnic', 'Hispanic or Latino - a person of Cuban, Mexican, Puerto Rico, South or Central', 'Categories:', 'American, or other Spanish culture or origin, regardless of race. The term \"Spanish', 'origin\" can also be used in addition to \"Hispanic or Latino.\"', 'Not Hispanic or Latino', 'Racial', 'American Indian or Alaskan Native - a person having origins in any of the original', 'Categories:', 'peoples of North, Central, or South America, and who maintains tribal affiliations or', 'community attachment.', 'Asian - a person having origins in any of the original peoples of the Far East,', 'Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China,', 'India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and', 'Vietnam. (Note: Individuals from the Philippine Islands have been recorded as Pacific', 'Islanders in previous data collection strategies.)', 'Black or African American - a person having origins in any of the black racial', 'groups of Africa. Terms such as \"Haitian\" or \"Negro\" can be used in addition to', '\"Black or African American.\"', 'Native Hawaiian or other Pacific Islander - a person having origins in any of', 'the', 'original peoples of Hawaii, Guam, Samoa, or other Pacific Islands.', 'White - a person having origins in any of the original peoples of Europe, the Middle', 'East, or North Africa.', '17.0', 'Pathology Considerations/Tissue Biospecimens', '17.1', 'Summary Table of Research Tissue Specimens to be Collected for this Protocol', 'Block,', 'Specimen', 'Slides, Core,', 'Process', 'Tempera', 'Research Study', 'Purpose', 'Mandat', 'Type of', 'etc. (# of', 'at site?', 'Conditi', '(Section for more', '(check all', 'ory or', 'Tissue to', 'each to', 'Archived', '(Yes or', 'for Stor', 'information)', 'that apply)', 'Optional', 'Collect', 'submit)', 'tissue', 'No)', '/Shipp', 'Correlative', 'Formalin', '5 charged', 'Correlative studies for', 'studies for', 'unstained', 'mRNA expression and', 'Fixed', 'mRNA', 'slides 5', 'whole genome analysis', 'Optional', 'Paraffin', 'X', 'No', 'Ambie', 'expression and', 'microns', 'Correlative Application', 'Embedded', 'MC1752-C1', 'whole genome', 'thick', 'analysis', 'sections', 'Protocol Version Date: 21JUN2018']\n\n###\n\n", "completion": "END"}